How Protocol Optimization Improves Clinical Trial Outcomes

Protocols are the foundation of effective clinical trials — targeting potential recruits, dosages, end points and much more. Human studies must have practically doable, well-thought-out protocols,
but the complexities of bringing new drugs to market make it extremely difficult for protocols to anticipate all the ways a trial can go astray.  In this article,  Sy Pretorius, chief scientific officer at Parexel International, offers a new framework for protocol optimization.
Previous Article
Early Phase Clinical Unit Tour - Baltimore
Early Phase Clinical Unit Tour - Baltimore

Take a tour

Next Flipbook
Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company
Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drug...